After participating in a brain research study, Steven Keating avidly collected and examined his personal medical data. Steven’s curiosity ultimately helped to identify his own brain tumor, a glioma, which was removed in the Advanced Multimodality Image Guided Operating Suite (AMIGO) at Brigham and Women’s Hospital in 2014. Based on this experience, Steven is now a vocal advocate of providing patients with open access to their medical information. In this video, Steven shares the incredible story of how his life-long curiosity helped identify his brain tumor – and how curiosity about medical data also can help others.
Posted by Brigham and Women's Hospital May 24, 2016
Posted by Brigham and Women's Hospital November 4, 2014
The Advanced Multimodality Image Guided Operating (AMIGO) suite at Brigham and Women’s Hospital is a state-of-the-art medical and surgical research environment that houses a vast array of advanced imaging equipment and interventional (minimally invasive) surgical systems. Multidisciplinary teams of specialists use the suite’s advanced technology and unique design to efficiently and precisely guide treatment — before, during, and after surgery — without the patient or medical team ever leaving the operating room.
The AMIGO suite gives physician-researchers an optimized setting for innovatively merging imaging and surgery to improve standard clinical procedures and to develop new therapeutic approaches. With the primary goal of improving the effectiveness of patient care, success already has been demonstrated in several treatment areas, including: image-guided therapy in open brain surgery, radiation treatment of prostate cancer and gynecological tumors, breast-conserving therapy, MRI-guided cryoablation (destroying diseased tissue via extreme cold), treatment of atrial and ventricular fibrillation, and brain tumor laser ablation (destroying diseased tissue with focused heat). In the following video, Dr. Steven Seltzer, Chair of the Department of Radiology at Brigham and Women’s Hospital (BWH) and Dr. Michael Zinner, Chair of the BWH Department of Surgery, offer an inside look at the AMIGO suite and detail its potential for improving the effectiveness of image-guided therapy.
Posted by Brigham and Women's Hospital October 2, 2014
Currently, up to 40 percent of patients undergoing breast-conserving surgery to treat cancer require re-operation because of a failure to remove all of the cancerous tissue during the initial operation. Brigham and Women’s Hospital (BWH) researchers, however, have successfully tested an innovative tissue imaging approach that accurately distinguishes cancerous breast tissue from normal breast tissue and precisely defines the margins between the two – an advance that could significantly decrease the need for follow-up surgery.
The tool the researchers used for their study is called desorption electrospray ionization (DESI) mass spectrometry imaging, a technology that allows physicians and researchers to promptly evaluate human tissue. It works by electrically charging (ionizing) molecules in a tissue sample through the application of a microscopic stream of solvent. The mass of these ionized molecules is then measured and their distribution within the tissue is mapped.
Posted by Brigham and Women's Hospital June 30, 2014
For many patients with brain tumors or other abnormal tissue located deep in the brain, treatment options have been limited. Last year, Jill Colter, now 50, discovered that a brain tumor resulting from Stage IV melanoma had returned. “Several years earlier, I had treatment with surgery and radiation, but the tumor came back,” Jill says. Due to the location of Jill’s tumor and her prior radiation, surgery and further radiation weren’t possible to treat her tumor.
Jill was referred to neurosurgeon Alexandra Golby, MD, Director of Image-guided Neurosurgery and Clinical Co-director of the Advanced Multimodality Image Guided Operating (AMIGO) Suite at Brigham and Women’s Hospital and a key member of the Center for Neuro-Oncology team at Dana-Farber/Brigham and Women’s Cancer Center.
Posted by Brigham and Women's Hospital January 30, 2013
When Jane Davis was diagnosed with breast cancer in July 2012, she began learning as much as she could about the disease. Davis quickly discovered one of the most startling statistics about breast cancer — that up to 40 percent of women in the U.S. who undergo a lumpectomy to remove a tumor require a second surgery. That’s because surgeons often are unable to microscopically remove the entire tumor during the first surgery.
Dr. Mehra Golshan, Director of Breast Surgical Services at Dana-Farber/Brigham and Women’s Cancer Center, is trying to change that with his research using image-guided therapy, available through the Advanced Multimodality Image Guided Operating (AMIGO) suite at Brigham and Women’s Hospital, to perform more precise breast surgeries.